#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nephroblastoma Type IIa hyperlipidaemia Stress cardiomyopathy Hyperinsulinaemic hypoglycaemia HER2 gene amplification Hypoparathyroidism Synovial sarcoma metastatic Choroidal dystrophy Liposarcoma recurrent Squamous cell carcinoma of the cervix Adenocarcinoma pancreas Alternating hemiplegia of childhood Lung adenocarcinoma Juvenile chronic myelomonocytic leukaemia Encephalitis autoimmune More trials…

    Learn about Rare Diseases

    Optic glioma – Life with Disease Cytokine release syndrome – Life with Disease Kearns-Sayre syndrome Alveolar rhabdomyosarcoma Inclusion body myositis Cystic fibrosis – Diagnostics Thrombotic thrombocytopenic purpura – Treatment Mucopolysaccharidosis – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Treatment Alveolar rhabdomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000017986 Patiromer Ranolazine Magnesium Citrate Mrna-3210 204-NETU SEVABERTINIB Nadunolimab Terlipressin Mosunetuzumab Microcrystalline Cellulose ZINC GLUCONATE Dacarbazine Citrate Blomia Tropicalis PROMESTRIENE Epcoritamab Esketamine ARFOLITIXORIN MOLNUPIRAVIR Ibrexafungerp More therapies…

    Learn about Your Condition

    Laryngeal cancer stage III Cardiac amyloidosis Colorectal adenocarcinoma Obsessive-compulsive disorder Irritable bowel syndrome Thromboangiitis obliterans Precocious puberty Arteriosclerosis Langerhans cell sarcoma Myotonic dystrophy Erosive oesophagitis Tachypnoea Infantile spasms Cognitive disorder Extraskeletal ossification More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute respiratory failure

  • Study of High-Flow Nasal Oxygen During Intubation in Intensive Care Patients with Low Blood Oxygen Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Oxygen
    France

  • Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

    Recruiting

    3 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Tozorakimab
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study on the Effects of Dexamethasone in Adults with Acute Respiratory Failure Due to Infections, Including COVID-19

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    Spain

  • Study on Anticoagulation Strategies with Heparin, Enoxaparin, and Argatroban for Patients with Respiratory or Circulatory Failure on ECMO Support

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory failure
    • Respiratory failure
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Argatroban Monohydrate
    • Enoxaparin Sodium
    • Heparin Sodium
    Austria

  • Study on Weaning Patients with Acute Respiratory Failure from High-Flow Nasal Oxygen Therapy Using Oxygen

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Oxygen
    France

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!